SCHEMBL7535843

SCHEMBL7535843

NC(=O)c1nc2cc(C(=O)O)ccc2o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 3/20 0.44
MBOAT4 Q96T53 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HDAC6 Q9UBN7 4/20 0.43
ALDH1A1 P00352 4/20 0.41
GAA P10253 3/20 0.41
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TTR P02766 3/20 0.40
ALB P02768 1/20 0.40
MAOA P21397 1/20 0.40
CNR1 P21554 1/20 0.40
DRD1 P21728 1/20 0.40
OPRD1 P41143 1/20 0.40
PDE4D Q08499 1/20 0.40
PDE3A Q14432 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11595567 0.87 NPC1 (0.46) NPC1RAB9ASMN1; SMN2HPGDMBOAT4
SCHEMBL6789233 0.80 MAPT (0.54) NPC1RAB9ASMN1; SMN2HPGDMBOAT4
SCHEMBL2701430 0.79 MAPT (0.57) NPC1RAB9ASMN1; SMN2HPGDTDP1
SCHEMBL6790090 0.78 TDP1 (0.47) NPC1RAB9ASMN1; SMN2HPGDMBOAT4
SCHEMBL25253664 0.77 HDAC6 (0.48) NPC1RAB9ASMN1; SMN2HPGDMBOAT4
SCHEMBL701884 0.77 TDP1 (0.54) NPC1RAB9ASMN1; SMN2HPGDMBOAT4
SCHEMBL30041235 0.77 TDP1 (0.54) NPC1RAB9ASMN1; SMN2HPGDMBOAT4
SCHEMBL29502366 0.77 HDAC6 (0.48) NPC1RAB9ASMN1; SMN2HPGDMBOAT4
SCHEMBL9305022 0.77 NPC1 (0.46) NPC1RAB9ASMN1; SMN2HPGDMBOAT4
SCHEMBL8653471 0.77 NPC1 (0.46) NPC1RAB9ASMN1; SMN2HPGDMBOAT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202731-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-05-08 EP disclosed
EP-1144385-A1 BENZOHETEROCYCLES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-10-17 EP disclosed
WO-2001005390-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO disclosed
WO-2000042022-A1 BENZOHETEROCYCLES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-07-20 WO disclosed